Featured News

Media Contact: Stephanie Bulak info@sidp.org

<< First  < Prev   1   2   3   4   5   ...   Next >  Last >> 
  • 14 Aug 2017 12:21 PM | Stephanie Bulak (Administrator)

    The Board of Directors of the Society of Infectious Diseases Pharmacists (SIDP) is pleased to announce the funding of research proposal for The Ocean Spray Prevention of Urinary Tract Infections Research Award.

    Proposal should follow the guidelines described in the RFP (click here) and then submitted electronically to BOTH Stephanie Bulak (sbulak@eami.com) and the Chair of the Research Awards Committee, Vanthida Huang (vhuang@midwestern.eduno later than 5 PM EST on Friday, September 1, 2017.Applications submitted after the application deadline, will not be considered. 


  • 17 Jul 2017 8:00 AM | David Ha (Administrator)

    New Certificate Program Fills Antimicrobial Stewardship Gap

    Alexandria, VA— Today the American Society of Consultant Pharmacists (ASCP) and the Society of Infectious Diseases Pharmacists (SIDP) launched a joint Long-Term Care (LTC) Antimicrobial Stewardship Certificate Program. This is a practice-based certificate program focused on the role that pharmacists play in the appropriate use of antimicrobial agents.

     

    “The White House and the Centers for Diseases Control and Prevention (CDC) have prioritized the increased threat of antibiotic resistance to public health, and specifically called for strengthening of antibiotic stewardship in LTC settings,” said Frank Grosso, RPh, ASCP’s Executive Director and CEO. “This certificate program will help strengthen antibiotic stewardship in LTC by aiding pharmacists’ knowledge in microbiology, pharmacology, and disease state management.”

     

    The CDC's Core Elements of Antibiotic Stewardship for Nursing Homes specifically calls on “nursing facilities to work with a consultant pharmacist who has received specialized infectious diseases or antibiotic stewardship training.   “This program further fulfills the pledge that SIDP has made to train pharmacists to improve public health and address antibiotic resistance by conducting antimicrobial stewardship programs. By partnering with ASCP, we are leveraging the expertise of both organizations into this unique program that meets the specialized training called for by CDC guidance,” said SIDP Immediate Past-President, Jason Gallagher, Pharm.D. BCPS, FCCP, FIDSA. Through online programming and live webinars, pharmacists will practice developing interventions at their practice site that aim to improve patient/resident care and clinical outcomes, lower health care costs, and prolong the longevity of antimicrobials.

     

    The Certificate Program, available at www.ProCE.com/SIDP-LTC, is a certified pharmacy education (CPE) activity, with CPE jointly provided by ProCE, ASCP, and SIDP. ProCE and ASCP are accredited by the Accreditation Council for Pharmacy Education as a providers of continuing pharmacy education. This activity is eligible for ACPE credit; for questions or more information, please contact ProCE at info@proce.com.

    The American Society of Consultant Pharmacists (ASCP) is the only international professional society devoted to optimal medication management and improved health outcomes for all older persons. ASCP's members manage and improve drug therapy and improve the quality of life of geriatric patients and other individuals residing in a variety of environments, including nursing facilities, sub-acute care and assisted living facilities, psychiatric hospitals, hospice programs, and home and community-based care. Learn more at www.ascp.com.

    The Society of Infectious Diseases Pharmacists (SIDP) is an association of pharmacists and other allied health care professionals committed to promoting the appropriate use of antimicrobial agents and supporting practice, teaching and research in infectious diseases. Learn more at www.sidp.org.


  • 02 Jun 2017 4:09 PM | David Ha (Administrator)

    The Society of Infectious Diseases Pharmacists (SIDP) is pleased to solicit nominations and applications for Fellowship in SIDP (FIDP). 

    The Fellowship distinction was developed to recognize outstanding SIDP members who have made a significant and sustained contribution to the area of infectious diseases and the mission of SIDP. 

    Successful applicants demonstrate a commitment to promoting the appropriate use of antimicrobials for the prevention and management of infectious diseases through leadership and collaboration in infectious diseases practice, education, research, and advocacy.

    CLICK HERE FOR FURTHER INFORMATION

  • 24 May 2017 1:49 PM | Stephanie Bulak (Administrator)

    SIDP Community Pharmacy Antimicrobial Stewardship Task Force publishes Outpatient Antibiotic Stewardship: Interventions and Opportunities in the Journal of the American Pharmacists Association. Click link below for full details:

    Outpatient Antibiotic Stewardship: Interventions and Opportunities

  • 16 May 2017 5:56 PM | David Ha (Administrator)

    Following up on the success in Vienna last year, a 2nd conference will be held on September 6-8 in Boston, MA: https://www.asm.org/index.php/2017-asm-escmid-conference

    Abstract submission closes on June 22 and deadline for Early Bird registration is on July 27.


  • 10 Apr 2017 10:09 AM | Stephanie Bulak (Administrator)

    The Society of Infectious Diseases Pharmacists

    2017 Call for Grant Applications to Fund

    SIDP Young Investigator Research Award

    SIDP/BioMerieux Microbial Diagnostics in Antimicrobial Stewardship

    SIDP/Nabriva Therapeutics Community-Acquired Bacterial Pneumonia Award

    SIDP/Accelerate Diagnostics Microbial Diagnostics in Antimicrobial Stewardship 

    The Board of Directors of the Society of Infectious Diseases Pharmacists (SIDP) is pleased to announce the availability of funding of four (4) research proposals for the period of October 1, 2017 through September 30, 2018.

    Proposals should follow the guidelines described in the RFP and then submitted electronically to BOTH Stephanie Bulak (sbulak@eami.com) and the Chair of the Research Awards Committee, Vanthida Huang (vhuang@midwstern.edu) no later than 5PM on Friday, June 30, 2017. Applications submitted after the application deadline, will not be considered.  Please click on the link below for further details.

    SIDP Young Investigator Research Award

    SIDP/BioMerieux Microbial Diagnostics in Antimicrobial Stewardship

    SIDP/Nabriva Therapeutics Community-Acquired Bacterial Pneumonia Award

    SIDP/Accelerate Diagnostics Microbial Diagnostics in Antimicrobial Stewardship 


  • 27 Feb 2017 6:21 PM | Stephanie Bulak (Administrator)

    Please consider nominating either a colleague or yourself for an SIDP Award, to be given at the Annual Meeting, San Diego, CA, October 3, 2017.  Each year, the Society recognizes the excellence of its members with the Young Investigator of the Year, Pharmacotherapy Paper of the Year, Clinician of the Year, and Gita Patel Best Practice Award.  In addition, a Distinguished Service Award may be awarded by the Society to recognize truly outstanding and lasting service (this award is not necessarily given annually). 

    Nominations need to be received by Monday, April 3, 2017.  Supporting materials for each nominee will be due Monday April 17, 2017.  Winners will be notified no later than Friday May 12, 2017.  All nominations and supporting materials can be sent to Greg Eschenauer, Chair of the Recognition Awards Committee at geschena@gmail.com

    Each award description, criteria and required supporting materials are detailed in the links below. These descriptions will also be available on the website. Please consider your deserving colleagues or yourself for these awards!

    Young Investigator of the Year

    Pharmacotherapy Paper of the Year

    Clinician of the Year

    Gita Patel Best Practice Award

    Distinguished Service Award


  • 14 Feb 2017 10:00 AM | David Ha (Administrator)

     

    Washington, D.C. – The Board of Pharmacy Specialties (BPS) is pleased to announce the approval of two new specialties; cardiology pharmacy and infectious diseases pharmacy. This announcement follows the final review of the petitions for each new specialty that took place during the BPS Board meeting held on February 8, 2017.

    Harold Godwin, the 2017 Chairman of the BPS Board of Directors and Professor Emeritus at the University of Kansas School of Pharmacy provided the following comments: “The Board of Pharmacy Specialties is very pleased to formally acknowledge two new pharmacy specialties. The recognition of these specialties further illustrates our growth as           a clinical profession and our ever increasing responsibilities in providing patient care. I want to also acknowledge the collaborative efforts of the four national pharmacy associations that developed these petitions. That type of collaboration is critical to the continued success of the pharmacy profession.”

    Cardiology Pharmacy

    Cardiology pharmacy becomes the tenth BPS specialty. The petition was submitted jointly by the American College of Clinical Pharmacy, American Pharmacists Association and the American Society of Health-System Pharmacists.

    The petitioning organizations have defined Cardiology Pharmacy practice as follows:

    Cardiology Pharmacy practice specializes in the delivery of direct patient care services by pharmacists as members of interprofessional healthcare teams, working to ensure the safe and effective use of medications in patients with cardiovascular disease. These specialists focus on disease prevention and treatment, including evidence-based medication use and related care that improve both short- and long-term outcomes for patients. Cardiology specialists practice across the spectrum of care, including ambulatory, acute and intensive care. Pharmacists in this practice review, analyze and monitor multifaceted clinical information to make reasoned decisions for patients with multiple comorbidities and highly complex mediation regimens.

    Infectious Diseases Pharmacy

    Infectious diseases pharmacy becomes the eleventh BPS specialty. The petition was submitted jointly by the American College of Clinical Pharmacy, American Pharmacists Association, American Society of Health-System Pharmacists and the Society of Infectious Diseases Pharmacists.

    The petitioning organizations have defined Infectious Diseases Pharmacy practice as follows:

    Infectious Diseases Pharmacy practice specializes in the use of microbiology and pharmacology to develop, implement, and monitor drug regimens that incorporate the pharmacodynamics and pharmacokinetics of antimicrobials to optimize therapy for patients. The practice requires pharmacists to use clinical and evidence-driven knowledge to develop appropriate antimicrobial therapies to more rapidly resolve infections while decreasing adverse events, complications and resistance. The practice includes direct patient care provided through interprofessional health care teams, collaborative leadership of antimicrobial stewardship programs, education of health care providers, preventive services including immunizations, and advocacy for appropriate antimicrobial utilization.

    Specialty pharmacy practice in infectious diseases uniquely improves public health by optimizing antimicrobial potential in individual patients and narrowing the resistance trends that occur in society by preventing progression of antimicrobial resistance and infectious diseases.


    Next Steps

    The next steps in the specialty certification process are outlined below:

    ·         BPS will issue a call during the first week of March 2017 for nominations to serve on the Cardiology and Infectious Diseases Pharmacy Specialty Councils. The closing date for nominations will be May 1, 2017.

    ·         BPS will appoint nine members to each Council by June 2, 2017.

    ·         The Councils will convene, on dates to be determined, in July 2017.

    ·         Examination item writing for the new specialties will begin during the third quarter of 2017 with a goal of offering the first examination in September 2018.

    Added Qualifications Program

    The BPS Board will re-evaluate the current Added Qualifications program. However, the Board anticipates that the Added Qualifications program for Cardiology and Infectious Diseases will end as of December 31, 2017 based upon the plan to offer the first examinations in those specialties in 2018. Individuals currently holding Added Qualifications can keep those credentials until they expire but will not be able to renew them. The National Commission for Certifying Agencies (NCCA) standards prohibit BPS from conferring Board Certification to those who hold Added Qualifications in either Cardiology or Infectious Diseases without passing the respective certification examination.

    William Ellis, BPS Executive Director added, “The growth of BPS and the addition of new specialties reflects the growth and maturation of the pharmacy profession. BPS is committed to being responsive and flexible in evaluating possible specialties that will improve patient care through recognition and promotion of specialized training, knowledge, and skills in pharmacy through the specialty board certification of pharmacists.”

    Eleven specialties are currently recognized by BPS including: (1) Nuclear Pharmacy, since 1978; (2) Nutrition Support Pharmacy, since 1988; (3) Pharmacotherapy, since 1988; (4) Psychiatric Pharmacy, since 1992; (5) Oncology

    Pharmacy, since 1996; (6) Ambulatory Care Pharmacy, since 2009; (7) Critical Care Pharmacy, since 2013; (8)

    Pediatric Pharmacy, since 2013; (9) Geriatric Pharmacy in 2017 (through CCGP); (10) Cardiology Pharmacy in 2017; and (11) Infectious Diseases Pharmacy in 2017. BPS certification exams are administered at over 500 locations worldwide, the Spring testing window application deadline is March 6, 2017 and the Fall 2017 registration will be open from May 8, 2017 until August 1, 2017. Candidates can register by going to the BPS website at  www.bpsweb.org.

    About the Board of Pharmacy Specialties

    The Board of Pharmacy Specialties (BPS) was established in 1976 as an autonomous division of the American Pharmacists Association (APhA). The mission of the Board of Pharmacy Specialties is to improve patient care and increase awareness of the need for BPS Board Certified Pharmacists as integral members of multidisciplinary healthcare teams through recognition and promotion of specialized training, knowledge, and skills in pharmacy and specialty board certification and recertification of pharmacists throughout the world.

    Board Certification through BPS has become recognized as the gold standard for determining which pharmacists are qualified to contribute at advanced practice levels as a result of the rigorous standards mandated by BPS board certification and recertification. Today over 30,000 pharmacists worldwide hold BPS certification.

    ###

    BPS CONTACT

    Ernest Wright ewright@aphanet.org 202-429-7510

    www.bpsweb.org


  • 05 Jan 2017 11:45 AM | Stephanie Bulak (Administrator)

    Completed 2017 YOUNG INVESTIGATOR PILOT AWARD APPLICATIONS (click here) are due by 5pm PDT on February 17, 2017. Applications should be submitted as pdf documents to CODCC@acsr.ucsf.edu

     

    The ACSR Young Investigator Pilot Award (YIPA) is targeted toward junior investigators and faculty with innovative ideas for translational, clinical and/or behavioral-epidemiological HIV-related research that utilizes ACSR’s annotated biospecimens collected from HIV/AIDS patients and controls from both pre and post-HAART periods. Awards are intended for pilot studies to show feasibility and/or to generate preliminary data that will support efforts to procure future funding of larger research projects.


  • 16 Dec 2016 9:48 AM | David Ha (Administrator)

    The ACSR Young Investigator Pilot Award (YIPA) is targeted toward junior investigators and faculty with innovative ideas for translational, clinical and/or behavioral-epidemiological HIV-related research that utilizes ACSR’s annotated biospecimens collected from HIV/AIDS patients and controls from both pre and post-HAART periods. Awards are intended for pilot studies to show feasibility and/or to generate preliminary data that will support efforts to procure future funding of larger research projects.

    Click here to learn more: https://acsr.ucsf.edu/?page_id=912/

<< First  < Prev   1   2   3   4   5   ...   Next >  Last >> 

Membership gives you more

  • Access exclusive opportunities
  • Connect with colleagues
  • Attend networking events

JOIN TODAY


Society of Infectious Diseases Pharmacists • 121 W. State Street, Geneva, IL 60134
630-318-3291 sidp@affinity-strategies.com
Proudly Managed by Affinity Strategies

Powered by Wild Apricot Membership Software